Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER: Iodixanol vs Ioxaglate in Renal Insufficiency Undergoing Coronary Angiography
NCT00247325Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of iodixanol in coronary heart disease (CHD) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of contrast induced nephropathy. Started Jan 2004; status: completed.
02
Drugs
iodixanol
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00247325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247325.